Candidiasis Treatment: An Evolutionary Journey from Past to Present and a Glimpse into the Future

The therapy of invasive candidiasis has evolved significantly over the last decade and must continue to adapt if we are to improve outcomes in this deadly infection. The treatment choices for this illness are numerous. The right technique must be selected based on the circumstances and the patient profile; occasionally, a combination of strategies is advised. Azoles, polyenes, and echinocandins are the three main therapeutic classes that are widely utilized. The success of those innovations is threatened by the rise in antibiotic resistance, though, which is encouraging researchers to keep looking for alternatives. Future changes to the management of invasive candidiasis may be influenced by these advancements as well as the continuous research underway on dose, toxicity, and resistance development.